• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/15 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/15

Total number of patents in this class: 331

10-year publication summary

27
35
19
27
24
21
30
40
27
19
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The Board of Trustees of the University of Illinois
2695
13
The Board of Regents of the University of Texas System
2207
9
Tetraphase Pharmaceuticals, Inc.
51
8
Novartis AG
10829
6
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1349
6
Pharmatrophix, Inc.
22
5
Ramot at Tel-Aviv University Ltd.
1477
5
University of Tennessee Research Foundation
758
5
Beam Therapeutics Inc.
242
5
Contemporary Amperex Technology (Hong Kong) Limited
3612
5
Rohm and Haas Company
2877
4
Dow Global Technologies LLC
10349
4
President and Fellows of Harvard College
5973
4
JSR Corporation
2527
4
West China Hospital, Sichuan University
198
4
Sanofi
4068
4
BASF SE
20915
3
Massachusetts Institute of Technology
10057
3
Korea Institute of Science and Technology
2123
3
Canopy Growth Corporation
221
3
Other owners 228